Post Categories
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease
March 26, 2019
QPS will exhibit at the 14th International Conference on Alzheimer’s & Parkinson’s Disease, March 26-31 in Lisbon, Portugal. Please stop by our booth #28…
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference
March 26, 2019
QPS is exhibiting at the 3rd Annual Gene Therapy for Rare Disorders Conference, between March 26-28 in Boston, MA. If you are attending the…
Spreading Early Clinical Knowledge
October 20, 2017
Shoulder to shoulder with our clients, we at QPS like to share the results of our early clinical research efforts, published in the scientific…
Translational Medicine Now Bigger and Better at QPS
July 14, 2017
Goodbye boutique CRO, hello large study BIG PLAYER! For a long time, you’ve known us as THE high quality outfit that can stabilize difficult…
QPS’ Paul Lehman to Speak at Transdermal & Intradermal Drug Delivery Conference
June 12, 2017
The 2017 Transdermal & Intradermal Drug Delivery Systems conference covering Advanced Design, Development & Delivery of Skin-Mediated Therapies and Vaccines is coming up on…
QPS Tapped for Two New FIH Studies
May 5, 2017
Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute…
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
May 2, 2017
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels…
QPS Sponsors Day 1 of World ADC Meeting in Berlin
February 20, 2017
QPS is the main sponsor of the Analytical and Bioanalytical Day at the 7th World ADC Meeting, February 20 – 22, 2017 at the…
QPS Assay Finder Database Grows 47 New Assays!
November 28, 2016
For all you assay aficionados out there, we thought you’d be juiced to know — we just added a whopping 47 new assays to…
Client Feedback — Our Gold Standard
December 13, 2016
At QPS, we love making customers happy. Here’s what two of them had to say about our work in DMPK protein binding studies: First…
QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year
December 5, 2016
For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and…
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics,…
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate…
FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription…
Amid Polio Outbreaks Around the World, Public Health Leaders Continue to Sound the Alarm
October 10, 2022
“Polio anywhere is a risk to people everywhere.” This public health mantra gets to the root of the problem. Polio remains endemic in Afghanistan…
Lymphatic Delivery Offers Potential Perks for Kinase Inhibitors and Other Cancer Drugs
October 3, 2022
A potential new cancer drug delivery method — through the gut’s lymphatic system rather than blood vessels — could improve treatment outcomes and reduce…
Burden of Disease by Social Status
September 28, 2022
Inequality in the United States has never been more apparent, especially in the wake of the COVID-19 pandemic. In a time when higher income…
Robotic Jumper Scales Tall Buildings in a Single Bound
September 26, 2022
Not unlike a superhero leaping into the air to protect humanity, a new jumping robot can reach a height of 30 meters (100 feet),…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
